Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2318 |
Sacubitril/Valsartan
Sacubitril mixture with Valsartan,沙库必曲/缬沙坦,Valsartan,Sacubitril,LCZ696 |
Apoptosis; RAAS; Neprilysin | Apoptosis; Endocrinology/Hormones; Metabolism |
Sacubitril/Valsartan (LCZ696),以1:1摩尔比由Valsartan(一种ARB)和Sacubitril(AHU377)组成,为创新口服血管紧张素受体-脑啡肽酶(ARN)双重抑制剂,旨在治疗高血压与心力衰竭。其作用机制包括抑制炎症、氧化应激及细胞凋亡,有助于改善糖尿病心肌病。 | |||
T19622 | (Z)2S,4R-Sacubitril | Others | Others |
(Z)2S,4R-Sacubitril is the impurity of Sacubitril. Sacubitril is used in combination with valsartan for the treatment of patients with heart failure. | |||
T19114L |
Sacubitril-(2S,4S)-Isomer
(2S,4S)-Sacubitril,LCZ 696杂质C |
Others | Others |
Sacubitril-(2S,4S)-Isomer ((2S,4S)-Sacubitril) 是 Sacubitril 的异构体,它是一种脑啡肽酶抑制剂。 | |||
T19114 |
(2S,4S)-Sacubitril
Sacubitril Impurity C,LCZ 696杂质C |
Others | Others |
(2S,4S)-Sacubitril (Sacubitril Impurity C) 是 Sacubitril 的杂质。其中 Sacubitril 是 NEP 抑制剂,可用于研究心力衰竭。 |